Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]
News [3678]
Articles [22]
Editorials [1]
Conferences [135]
elearning [0]
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in...
Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer ( Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
12 Jun 2020
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based...
Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer ( Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy )
12 Jun 2020
ASCO 2020: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ASCO 2020: Breast cancer roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
11 Jun 2020
COVID-19: Optimising supportive care during active cancer treatment
Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK
COVID-19: Optimising supportive care during active cancer treatment ( Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK )
10 Jun 2020
ASCO 2020: Updates in renal cancer
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO 2020: Updates in renal cancer ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
5 Jun 2020
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as...
Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta...
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC ( Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, USA )
2 Jun 2020
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after...
Prof Thomas Powles - Barts Cancer Institute, London, UK
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles - Barts Cancer Institute, London, UK )
29 May 2020
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell...
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
29 May 2020
COVID-19: Treating breast cancer and the knock on effects of the coronavirus...
Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )
28 May 2020
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )
22 May 2020
IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator...
Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA
IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC ( Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA )
19 May 2020
Gynaecological cancers in the era of fertility preservation
Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy
Gynaecological cancers in the era of fertility preservation ( Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy )
6 May 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation